Trade Summary

4 days ago, Coyne Terrance P., serving as EVP, CFO at Royalty Pharma Plc (RPRX), sold 34,791 shares at $45.32 per share, for a total transaction value of $1,576,606.00. Following this transaction, Coyne Terrance P. now holds 229,690 shares of RPRX.

This sale represents a 13.00% decrease in Coyne Terrance P.'s stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Monday, February 23, 2026 and publicly disclosed via SEC Form 4 filing on Wednesday, February 25, 2026, 2 days after the trade was made.

Royalty Pharma Plc operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.